Kyoto, Japan

Peishi Yan

This inventor holds 1 USPTO granted patent. Top assignee: Kyoto University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peishi Yan. Retrieved from https://idiyas.com/inventor/peishi-yan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peishi Yan: Innovator in Cardiac Stem Cell Research

Introduction

Peishi Yan is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of regenerative medicine, particularly in the production of cardiac cells. His work focuses on harnessing the potential of stem cells to address heart-related ailments.

Latest Patents

Peishi Yan holds a patent for his invention titled "Efficient production and use of highly cardiogenic progenitors and cardiomyocytes from embryonic and induced pluripotent stem cells." This invention relates to a method for producing cardiomyocytes and/or cardiac progenitor cells. The process involves culturing an induced pluripotent stem (iPS) cell or embryonic stem (ES) cell, which has been differentiated into a mesoderm cell, in the presence of cyclosporin-A. He has 1 patent to his name.

Career Highlights

Peishi Yan is affiliated with Kyoto University, where he conducts his research and development in the field of stem cell technology. His work has garnered attention for its potential applications in treating cardiovascular diseases.

Collaborations

Peishi Yan collaborates with Jun Yamashita, who is also involved in research related to cardiac stem cells. Their partnership enhances the scope and impact of their research efforts.

Conclusion

Peishi Yan's innovative work in cardiac stem cell research positions him as a key figure in the advancement of regenerative medicine. His contributions have the potential to significantly improve treatment options for heart diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…